PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.75%
Some net income increase while MCHP is negative at -68.80%. John Neff would see a short-term edge over the struggling competitor.
-2.62%
Negative yoy D&A while MCHP is 0.80%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-7.04%
Negative yoy deferred tax while MCHP stands at 585.47%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-6.52%
Negative yoy SBC while MCHP is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
56.25%
Well above MCHP's 49.18% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
183.87%
AR growth of 183.87% while MCHP is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-62.26%
Negative yoy inventory while MCHP is 185.66%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-140.58%
Negative yoy usage while MCHP is 27.77%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
255.56%
Well above MCHP's 126.61%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
20.02%
Operating cash flow growth below 50% of MCHP's 1610.31%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-92.92%
Negative yoy CapEx while MCHP is 55.69%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
5.01%
Some yoy expansion while MCHP is negative at -330.79%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
300.00%
1.25-1.5x MCHP's 209.91%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
No Data
No Data available this quarter, please select a different quarter.
31.47%
We have mild expansions while MCHP is negative at -50.80%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
11.76%
Lower share issuance yoy vs. MCHP's 600.89%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-40.24%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.